ClearanceBrief
510(k) K210126 ยท CAF Nebulizer (Direct Patient Interface)

Sodium Chloride Inhalation Solutions, 3%, 3.5%, 7% and 10%

ApplicantThe Ritedose Corporation, Columbia SC, US
DecisionSubstantially Equivalent, Dec 3, 2021
ReceivedJan 19, 2021
TypeTraditional
FDA recordOpen on fda.gov

Recalls that name K210126

No recall in the FDA data names this 510(k).

Links come from the 510(k) numbers listed on each FDA recall record. We don't infer predicate chains.